Exploitation of the 3-Quinolinecarbonitrile Template for Src Tyrosine Kinase Inhibitors

Author(s): Diane H. Boschelli

Journal Name: Current Topics in Medicinal Chemistry

Volume 8 , Issue 10 , 2008

Become EABM
Become Reviewer
Call for Editor


In 2000, Wyeth reported that the 3-quinolinecarbonitrile ring system was a template for EGFR inhibitors. It soon became apparent that the group at C-4 of this core was responsible for kinase selectivity. A 4-(2,4-dichloro-5- methoxyanilino) substituent provided potent inhibitors of Src, a non-receptor tyrosine kinase that plays a key role in cell signaling. One compound from this series, SKI-606, bosutinib, is currently in clinical trials for the treatment of cancer.

Keywords: 3-Quinolinecarbonitrile, kinase, Src, cancer, Abl, CML, SKI-606, bosutinib

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [922 - 934]
Pages: 13
DOI: 10.2174/156802608784911653
Price: $65

Article Metrics

PDF: 3